name,category,termsB-cell CLL/lymphoma 3,COG_ONTOLOGY[90000073$General function prediction only]
B-cell CLL/lymphoma 3,INTERPRO[450001870$IPR002110:Ankyrin]
B-cell CLL/lymphoma 3,OMIM_DISEASE[520002872$Leukemia/lymphoma, B-cell, 3]
B-cell CLL/lymphoma 3,SMART[760000220$SM00248:ANK]
B-cell CLL/lymphoma 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000086$ank repeat, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001271$Proto-oncogene, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation]
B-cell CLL/lymphoma 3,UP_SEQ_FEATURE[850007053$chain:B-cell lymphoma 3 protein, 850102586$compositionally biased region:Pro-rich, 850102592$compositionally biased region:Pro/Ser-rich, 850105852$helix, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850115657$repeat:ANK 6, 850115658$repeat:ANK 7, 850118624$turn]
BCL6 co-repressor,INTERPRO[450001870$IPR002110:Ankyrin]
BCL6 co-repressor,OMIM_DISEASE[520003306$Microphthalmia, syndromic 2]
BCL6 co-repressor,SMART[760000220$SM00248:ANK]
BCL6 co-repressor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000086$ank repeat, 790000311$chromatin regulator, 790000356$complete proteome, 790000446$disease mutation, 790000958$microphthalmia, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
BCL6 co-repressor,UP_SEQ_FEATURE[850007427$chain:BCL-6 corepressor, 850102568$compositionally biased region:Poly-Asp, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850106259$mutagenesis site, 850112123$region of interest:Interaction with BCL6, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 31,INTERPRO[450000537$IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450010405$IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012608$IPR014014:RNA helicase, DEAD-box type, Q motif, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 31,SMART[760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 31,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001065$nucleus, 790001212$polymorphism, 790001339$rna-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 31,UP_SEQ_FEATURE[850041108$chain:Probable ATP-dependent RNA helicase DDX31, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117383$short sequence motif:DEAD box, 850117676$short sequence motif:Q motif, 850118574$splice variant]
GATA binding protein 4,BIOCARTA[30000015$h_alkPathway:ALK in cardiac myocytes, 30000140$h_hopPathway:Hop Pathway in Cardiac Development, 30000199$h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart)]
GATA binding protein 4,INTERPRO[450000580$IPR000679:Zinc finger, GATA-type, 450007350$IPR008013:GATA-type transcription activator, N-terminal, 450011732$IPR013088:Zinc finger, NHR/GATA-type, 450014696$IPR016375:Transcription factor GATA-4/5/6]
GATA binding protein 4,OMIM_DISEASE[520000453$Atrial septal defect-2]
GATA binding protein 4,PIR_SUPERFAMILY[630003117$PIRSF003028:TF_GATA_4/5/6, 630003118$PIRSF003028:transcription factor GATA-4/5/6 types]
GATA binding protein 4,SMART[760000352$SM00401:ZnF_GATA]
GATA binding protein 4,SP_PIR_KEYWORDS[790000020$activator, 790000141$atrial septal defect, 790000245$Cardiomyopathy, 790000356$complete proteome, 790000446$disease mutation, 790000449$DNA binding, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
GATA binding protein 4,UP_SEQ_FEATURE[850065172$chain:Transcription factor GATA-4, 850102565$compositionally biased region:Poly-Ala, 850102582$compositionally biased region:Poly-Thr, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118823$zinc finger region:GATA-type 1, 850118824$zinc finger region:GATA-type 2]
Hermansky-Pudlak syndrome 1,OMIM_DISEASE[520002302$Hermansky-Pudlak syndrome 1]
Hermansky-Pudlak syndrome 1,PIR_SUPERFAMILY[630028443$PIRSF036954:HPS1]
Hermansky-Pudlak syndrome 1,SP_PIR_KEYWORDS[790000035$Albinism, 790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000676$Hermansky-Pudlak syndrome, 790001212$polymorphism, 790001304$repeat, 790001377$sensory transduction, 790001622$vision]
Hermansky-Pudlak syndrome 1,UP_SEQ_FEATURE[850023530$chain:Hermansky-Pudlak syndrome 1 protein, 850102572$compositionally biased region:Poly-Glu, 850117290$repeat:[DE]-X(4)-L-L 1, 850117291$repeat:[DE]-X(4)-L-L 2, 850117292$repeat:[DE]-X(4)-L-L 3, 850117293$repeat:[DE]-X(4)-L-L 4, 850117294$sequence conflict, 850117295$sequence variant, 850117575$short sequence motif:Melanosome targeting signal, 850118574$splice variant]
KIAA0427,INTERPRO[450003415$IPR003890:MIF4G-like, type 3, 450014420$IPR016021:MIF4-like, type 1/2/3]
KIAA0427,SMART[760000483$SM00543:MIF4G]
KIAA0427,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001043$nonsense-mediated mrna decay, 790001162$phosphoprotein, 790001212$polymorphism, 790001551$translation regulation]
KIAA0427,UP_SEQ_FEATURE[850010071$chain:CBP80/20-dependent translation initiation factor, 850104778$domain:MIF4G, 850106258$modified residue, 850112588$region of interest:Interaction with NCBP1/CBP80, 850117295$sequence variant, 850118574$splice variant]
LUC7-like (S. cerevisiae),INTERPRO[450004355$IPR004882:LUC7 related]
LUC7-like (S. cerevisiae),PIR_SUPERFAMILY[630021697$PIRSF028830:Luc7/Luc7-like protein, 630030647$PIRSF500423:Luc7-like protein]
LUC7-like (S. cerevisiae),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000937$metal-binding, 790001162$phosphoprotein, 790001648$zinc, 790001651$zinc-finger]
LUC7-like (S. cerevisiae),UP_SEQ_FEATURE[850054263$chain:Putative RNA-binding protein Luc7-like 1, 850102442$compositionally biased region:Arg/Ser-rich, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118740$zinc finger region:C2H2-type; atypical]
MYB binding protein (P160) 1a,INTERPRO[450006411$IPR007015:DNA polymerase V]
MYB binding protein (P160) 1a,SP_PIR_KEYWORDS[790000012$acetylation, 790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
MYB binding protein (P160) 1a,UP_SEQ_FEATURE[850032868$chain:Myb-binding protein 1A, 850102507$compositionally biased region:Glu-rich, 850106258$modified residue, 850112572$region of interest:Interaction with MYB, 850114435$region of interest:Required for nuclear and nucleolar localization, 850117294$sequence conflict, 850117295$sequence variant, 850117606$short sequence motif:Nuclear export signal 1, 850117607$short sequence motif:Nuclear export signal 2, 850118574$splice variant]
WD repeat domain 81,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 81,SMART[760000289$SM00320:WD40]
WD repeat domain 81,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 81,UP_SEQ_FEATURE[850100781$chain:WD repeat-containing protein 81, 850102507$compositionally biased region:Glu-rich, 850102573$compositionally biased region:Poly-Gly, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
amyloid beta (A4) precursor protein-binding, family B, member 2,INTERPRO[450001055$IPR001202:WW/Rsp5/WWP, 450005462$IPR006020:Phosphotyrosine interaction region, 450010818$IPR011993:Pleckstrin homology-type]
amyloid beta (A4) precursor protein-binding, family B, member 2,OMIM_DISEASE[520000242$Alzheimer disease, late-onset]
amyloid beta (A4) precursor protein-binding, family B, member 2,SMART[760000401$SM00456:WW, 760000407$SM00462:PTB]
amyloid beta (A4) precursor protein-binding, family B, member 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001304$repeat]
amyloid beta (A4) precursor protein-binding, family B, member 2,UP_SEQ_FEATURE[850005172$chain:Amyloid beta A4 precursor protein-binding family B member 2, 850104994$domain:PID 1, 850104995$domain:PID 2, 850105731$domain:WW, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
carcinoembryonic antigen-related cell adhesion molecule 7,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450012396$IPR013783:Immunoglobulin-like fold]
carcinoembryonic antigen-related cell adhesion molecule 7,PIR_SUPERFAMILY[630002149$PIRSF002013:biliary glycoprotein]
carcinoembryonic antigen-related cell adhesion molecule 7,SMART[760000357$SM00409:IG]
carcinoembryonic antigen-related cell adhesion molecule 7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000628$gpi-anchor, 790000768$Immunoglobulin domain, 790000881$lipoprotein, 790000919$membrane, 790001149$phosphatidylinositol linkage, 790001212$polymorphism, 790001304$repeat, 790001405$signal]
carcinoembryonic antigen-related cell adhesion molecule 7,UP_SEQ_FEATURE[850009693$chain:Carcinoembryonic antigen-related cell adhesion molecule 7, 850102883$disulfide bond, 850104355$domain:Ig-like C2-type, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850105861$lipid moiety-binding region:GPI-anchor amidated serine, 850109701$propeptide:Removed in mature form, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
chromosome 19 open reading frame 22,INTERPRO[450001219$IPR001374:Single-stranded nucleic acid binding R3H]
chromosome 19 open reading frame 22,SMART[760000345$SM00393:R3H]
chromosome 19 open reading frame 22,SP_PIR_KEYWORDS[790000356$complete proteome, 790001065$nucleus]
chromosome 19 open reading frame 22,UP_SEQ_FEATURE[850056504$chain:R3H domain-containing protein C19orf22, 850102404$compositionally biased region:Arg-rich, 850105134$domain:R3H]
crystallin, gamma D,INTERPRO[450000933$IPR001064:Beta and gamma crystallin]
crystallin, gamma D,OMIM_DISEASE[520000841$Cataract, congenital, cerulean type, 3, 520000848$Cataract, crystalline aculeiform, 520000854$Cataract, nonnuclear polymorphic congenital, 520000858$Cataract, polymorphic congenital, 520000873$Cataracts, punctate, progressive juvenile-onset]
crystallin, gamma D,PIR_SUPERFAMILY[630002405$PIRSF002281:beta/gamma crystallins, 630030672$PIRSF500453:gamma crystallin]
crystallin, gamma D,SMART[760000219$SM00247:XTALbg]
crystallin, gamma D,SP_PIR_KEYWORDS[790000002$3d-structure, 790000252$cataract, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000473$duplication, 790000534$eye lens protein, 790001089$oxidation, 790001212$polymorphism, 790001304$repeat, 790001377$sensory transduction, 790001622$vision]
crystallin, gamma D,UP_SEQ_FEATURE[850020516$chain:Gamma-crystallin D, 850103104$domain:Beta/gamma crystallin 'Greek key' 1, 850103108$domain:Beta/gamma crystallin 'Greek key' 2, 850103109$domain:Beta/gamma crystallin 'Greek key' 3, 850103110$domain:Beta/gamma crystallin 'Greek key' 4, 850105852$helix, 850106259$mutagenesis site, 850111296$region of interest:Connecting peptide, 850117295$sequence variant, 850118568$site:Susceptible to oxidation, 850118575$strand, 850118624$turn]
fatty acid desaturase domain family, member 6,INTERPRO[450005254$IPR005804:Fatty acid desaturase, type 1]
fatty acid desaturase domain family, member 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000542$Fatty acid biosynthesis, 790000874$lipid synthesis, 790000919$membrane, 790001092$oxidoreductase, 790001304$repeat, 790001555$transmembrane]
fatty acid desaturase domain family, member 6,UP_SEQ_FEATURE[850019047$chain:Fatty acid desaturase 6, 850110255$region of interest:3 X 6 AA tandem repeat of M-E-P-T-E-P, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850117294$sequence conflict, 850117484$short sequence motif:Histidine box-1, 850117485$short sequence motif:Histidine box-2, 850117486$short sequence motif:Histidine box-3, 850118574$splice variant, 850118623$transmembrane region]
fibronectin type III and SPRY domain containing 1,INTERPRO[450001654$IPR001870:B302 (SPRY)-like, 450003195$IPR003649:B-box, C-terminal, 450003405$IPR003877:SPla/RYanodine receptor SPRY, 450003484$IPR003961:Fibronectin, type III, 450008173$IPR008957:Fibronectin, type III-like fold, 450016218$IPR017903:COS domain]
fibronectin type III and SPRY domain containing 1,SMART[760000051$SM00060:FN3, 760000445$SM00502:BBC]
fibronectin type III and SPRY domain containing 1,SP_PIR_KEYWORDS[790000258$cell cycle, 790000260$cell division, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000960$microtubule, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
fibronectin type III and SPRY domain containing 1,UP_SEQ_FEATURE[850019435$chain:Fibronectin type III and SPRY domain- containing protein 1, 850103078$domain:B30.2/SPRY, 850103408$domain:COS, 850103799$domain:Fibronectin type-III, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant]
furin (paired basic amino acid cleaving enzyme),BIOCARTA[30000207$h_notchpathway:Proteolysis and Signaling Pathway of Notch ]
furin (paired basic amino acid cleaving enzyme),INTERPRO[450000180$IPR000209:Peptidase S8 and S53, subtilisin, kexin, sedolisin, 450002550$IPR002884:Proprotein convertase, P, 450005638$IPR006212:Furin-like repeat, 450013941$IPR015500:Peptidase S8, subtilisin-related]
furin (paired basic amino acid cleaving enzyme),PIR_SUPERFAMILY[630001322$PIRSF001179:proprotein convertase, subtilisin/kexin types, 630030565$PIRSF500329:furin]
furin (paired basic amino acid cleaving enzyme),SMART[760000233$SM00261:FU]
furin (paired basic amino acid cleaving enzyme),SP_PIR_KEYWORDS[790000144$autocatalytic cleavage, 790000211$calcium, 790000264$cell membrane, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000624$golgi apparatus, 790000743$hydrolase, 790000919$membrane, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001252$Protease, 790001383$Serine protease, 790001386$serine proteinase, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein, 790001652$zymogen]
furin (paired basic amino acid cleaving enzyme),UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850020185$chain:Furin, 850102480$compositionally biased region:Cys-rich, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105910$metal ion-binding site:Calcium 1, 850105918$metal ion-binding site:Calcium 2, 850106258$modified residue, 850109663$propeptide:Inhibition peptide, 850111222$region of interest:Cell surface signal, 850117295$sequence variant, 850117335$short sequence motif:Cell attachment site, 850117748$short sequence motif:Trans Golgi network signal, 850117814$signal peptide, 850117976$site:Cleavage, first; by autolysis, 850117977$site:Cleavage, second; by autolysis, 850118623$transmembrane region]
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding),INTERPRO[450005639$IPR006213:Bax inhibitor 1, conserved site, 450005640$IPR006214:Uncharacterised protein family UPF0005]
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding),SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding),UP_SEQ_FEATURE[850021596$chain:Glutamate [NMDA] receptor-associated protein 1, 850102586$compositionally biased region:Pro-rich, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
interferon-related developmental regulator 1,INTERPRO[450006320$IPR006921:Interferon-related developmental regulator, C-terminal, 450007056$IPR007701:Interferon-related developmental regulator, N-terminal]
interferon-related developmental regulator 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790001162$phosphoprotein]
interferon-related developmental regulator 1,UP_SEQ_FEATURE[850026478$chain:Interferon-related developmental regulator 1, 850102565$compositionally biased region:Poly-Ala, 850102573$compositionally biased region:Poly-Gly, 850106258$modified residue, 850117294$sequence conflict]
leucine rich repeat containing 8 family, member A,COG_ONTOLOGY[90000070$Function unknown]
leucine rich repeat containing 8 family, member A,INTERPRO[450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype]
leucine rich repeat containing 8 family, member A,OMIM_DISEASE[520000169$Agammaglobulinemia, non-Bruton type]
leucine rich repeat containing 8 family, member A,SMART[760000333$SM00369:LRR_TYP]
leucine rich repeat containing 8 family, member A,SP_PIR_KEYWORDS[790000012$acetylation, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000434$differentiation, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000853$leucine-rich repeat, 790000919$membrane, 790001162$phosphoprotein, 790001304$repeat, 790001555$transmembrane]
leucine rich repeat containing 8 family, member A,UP_SEQ_FEATURE[850028429$chain:Leucine-rich repeat-containing protein 8A, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116312$repeat:LRR 13, 850116313$repeat:LRR 14, 850116314$repeat:LRR 15, 850116315$repeat:LRR 16, 850116316$repeat:LRR 17, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
major vault protein,INTERPRO[450002218$IPR002499:Major vault protein, N-terminal]
major vault protein,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000990$mRNA transport, 790001048$nuclear pore complex, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001304$repeat, 790001325$ribonucleoprotein, 790001554$translocation, 790001558$transport]
major vault protein,UP_SEQ_FEATURE[850030236$chain:Major vault protein, 850105852$helix, 850106258$modified residue, 850116392$repeat:MVP 1, 850116393$repeat:MVP 2, 850116394$repeat:MVP 3, 850116395$repeat:MVP 4, 850116396$repeat:MVP 5, 850116397$repeat:MVP 6, 850116398$repeat:MVP 7, 850116399$repeat:MVP 8, 850116400$repeat:MVP 9, 850117295$sequence variant, 850118575$strand]
matrix metallopeptidase 24 (membrane-inserted),INTERPRO[450000498$IPR000585:Hemopexin/matrixin, 450001611$IPR001818:Peptidase M10A and M12B, matrixin and adamalysin, 450002196$IPR002477:Peptidoglycan binding-like, 450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450005466$IPR006026:Peptidase, metallopeptidases, 450014617$IPR016293:Peptidase M10A, matrix metallopeotidase, 450016760$IPR018486:Hemopexin/matrixin, conserved site, 450016761$IPR018487:Hemopexin/matrixin, repeat]
matrix metallopeptidase 24 (membrane-inserted),OMIM_DISEASE[520003072$Many sequence variants affecting diversity of adult human height]
matrix metallopeptidase 24 (membrane-inserted),PIR_SUPERFAMILY[630001331$PIRSF001191:matrix metalloproteinase, stromelysin type, 630001332$PIRSF001191:Peptidase_M10A_matrix]
matrix metallopeptidase 24 (membrane-inserted),SMART[760000105$SM00120:HX, 760000207$SM00235:ZnMc]
matrix metallopeptidase 24 (membrane-inserted),SP_PIR_KEYWORDS[790000211$calcium, 790000264$cell membrane, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000447$disulfide bond, 790000530$extracellular matrix, 790000743$hydrolase, 790000919$membrane, 790000937$metal-binding, 790000941$metalloprotease, 790001162$phosphoprotein, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001555$transmembrane, 790001648$zinc, 790001652$zymogen]
matrix metallopeptidase 24 (membrane-inserted),UP_SEQ_FEATURE[850030646$chain:Matrix metalloproteinase-24, 850044439$chain:Processed matrix metalloproteinase-24, 850102566$compositionally biased region:Poly-Arg, 850102883$disulfide bond, 850104116$domain:Hemopexin-like 1, 850104117$domain:Hemopexin-like 2, 850104118$domain:Hemopexin-like 3, 850104119$domain:Hemopexin-like 4, 850106244$metal ion-binding site:Zinc; catalytic, 850106245$metal ion-binding site:Zinc; in inhibited form, 850106258$modified residue, 850117295$sequence variant, 850117368$short sequence motif:Cysteine switch, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
megakaryoblastic leukemia (translocation) 1,INTERPRO[450002665$IPR003034:DNA-binding SAP, 450003537$IPR004018:RPEL repeat]
megakaryoblastic leukemia (translocation) 1,OMIM_DISEASE[520003118$Megakaryoblastic leukemia, acute]
megakaryoblastic leukemia (translocation) 1,SMART[760000456$SM00513:SAP, 760000614$SM00707:RPEL]
megakaryoblastic leukemia (translocation) 1,SP_PIR_KEYWORDS[790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation]
megakaryoblastic leukemia (translocation) 1,UP_SEQ_FEATURE[850032202$chain:MKL/myocardin-like protein 1, 850102485$compositionally biased region:Gln-rich, 850102586$compositionally biased region:Pro-rich, 850105257$domain:SAP, 850106258$modified residue, 850113384$region of interest:Mediates interaction with SCAI and ACTB, 850116934$repeat:RPEL 1, 850116935$repeat:RPEL 2, 850117295$sequence variant, 850117933$site:Breakpoint for translocation to form RBM15-MKL1]
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2,BBID[10000087$67.Ikaros_and_signaling_inhibitors]
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2,INTERPRO[450000384$IPR000451:NF-kappa-B/Rel/dorsal, 450002569$IPR002909:Cell surface receptor IPT/TIG, 450007644$IPR008366:Nuclear factor of activated T cells (NFAT), 450010400$IPR011539:Rel homology, 450012396$IPR013783:Immunoglobulin-like fold, 450016570$IPR018286:Nuclear factor of activated T cells (NFAT), subgroup]
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038846$hsa04310:Wnt signaling pathway, 470038851$hsa04360:Axon guidance, 470038852$hsa04370:VEGF signaling pathway, 470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038869$hsa04660:T cell receptor signaling pathway, 470038870$hsa04662:B cell receptor signaling pathway]
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2,SMART[760000375$SM00429:IPT]
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation]
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2,UP_SEQ_FEATURE[850034859$chain:Nuclear factor of activated T-cells, cytoplasmic 2, 850105182$domain:RHD, 850105852$helix, 850106258$modified residue, 850110285$region of interest:3 X approximate SP repeats, 850111160$region of interest:Calcineurin-binding, 850114281$region of interest:Required for cytoplasmic retention of the phosphorylated form, 850114895$region of interest:Trans-activation domain A (TAD-A), 850115074$repeat:1, 850115273$repeat:2, 850115463$repeat:3; approximate, 850117294$sequence conflict, 850117295$sequence variant, 850117605$short sequence motif:Nuclear export signal, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118575$strand, 850118624$turn]
oxysterol binding protein-like 1A,INTERPRO[450000555$IPR000648:Oxysterol-binding protein, 450001635$IPR001849:Pleckstrin homology, 450001870$IPR002110:Ankyrin, 450010818$IPR011993:Pleckstrin homology-type, 450016766$IPR018494:Oxysterol-binding protein, conserved site]
oxysterol binding protein-like 1A,OMIM_DISEASE[520000060$A Genome-Wide Association Study Identifies Protein Quantitative Trait Loci (pQTLs)]
oxysterol binding protein-like 1A,SMART[760000205$SM00233:PH, 760000220$SM00248:ANK]
oxysterol binding protein-like 1A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000344$coiled coil, 790000356$complete proteome, 790000875$lipid transport, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001558$transport]
oxysterol binding protein-like 1A,UP_SEQ_FEATURE[850036534$chain:Oxysterol-binding protein-related protein 1, 850104979$domain:PH, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
pantothenate kinase 4,INTERPRO[450002474$IPR002791:Domain of unknown function DUF89, 450004060$IPR004567:Eukaryotic pantothenate kinase, 450010433$IPR011602:Fumble, 450014268$IPR015844:Pantothenate kinase, acetyl-CoA regulated, two-domain type]
pantothenate kinase 4,KEGG_PATHWAY[470038797$hsa00770:Pantothenate and CoA biosynthesis]
pantothenate kinase 4,PIR_SUPERFAMILY[630008504$PIRSF009355:pantothenate kinase, acetyl-CoA regulated, stand-alone type, 630028421$PIRSF036939:PanK_long, 630028422$PIRSF036939:pantothenate kinase, acetyl-CoA regulated, two-domain type]
pantothenate kinase 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000342$coenzyme a biosynthesis, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790001063$nucleotide-binding, 790001212$polymorphism, 790001547$transferase]
pantothenate kinase 4,UP_SEQ_FEATURE[850036795$chain:Pantothenate kinase 4, 850106258$modified residue, 850117295$sequence variant]
peptidylprolyl isomerase A (cyclophilin A)-like 4E; peptidylprolyl isomerase A (cyclophilin A)-like 4G; peptidylprolyl isomerase A (cyclophilin A)-like 4F; peptidylprolyl isomerase A (cyclophilin A)-like 4A; peptidylprolyl isomerase A (cyclophilin A)-like 4C; peptidylprolyl isomerase A (cyclophilin A)-like 4B,INTERPRO[450001888$IPR002130:Peptidyl-prolyl cis-trans isomerase, cyclophilin-type]
peptidylprolyl isomerase A (cyclophilin A)-like 4E; peptidylprolyl isomerase A (cyclophilin A)-like 4G; peptidylprolyl isomerase A (cyclophilin A)-like 4F; peptidylprolyl isomerase A (cyclophilin A)-like 4A; peptidylprolyl isomerase A (cyclophilin A)-like 4C; peptidylprolyl isomerase A (cyclophilin A)-like 4B,PIR_SUPERFAMILY[630001630$PIRSF001467:peptidylprolyl isomerase]
peptidylprolyl isomerase A (cyclophilin A)-like 4E; peptidylprolyl isomerase A (cyclophilin A)-like 4G; peptidylprolyl isomerase A (cyclophilin A)-like 4F; peptidylprolyl isomerase A (cyclophilin A)-like 4A; peptidylprolyl isomerase A (cyclophilin A)-like 4C; peptidylprolyl isomerase A (cyclophilin A)-like 4B,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000810$Isomerase, 790001343$Rotamase]
peptidylprolyl isomerase A (cyclophilin A)-like 4E; peptidylprolyl isomerase A (cyclophilin A)-like 4G; peptidylprolyl isomerase A (cyclophilin A)-like 4F; peptidylprolyl isomerase A (cyclophilin A)-like 4A; peptidylprolyl isomerase A (cyclophilin A)-like 4C; peptidylprolyl isomerase A (cyclophilin A)-like 4B,UP_SEQ_FEATURE[850037701$chain:Peptidylprolyl cis-trans isomerase A-like 4A, 850037702$chain:Peptidylprolyl cis-trans isomerase A-like 4B, 850105057$domain:PPIase cyclophilin-type, 850117294$sequence conflict]
pre-B lymphocyte 1,INTERPRO[450003157$IPR003596:Immunoglobulin V-set, subgroup, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450012396$IPR013783:Immunoglobulin-like fold]
pre-B lymphocyte 1,PIR_SUPERFAMILY[630030247$PIRSF038787:immunoglobulin iota chain]
pre-B lymphocyte 1,SMART[760000354$SM00406:IGv]
pre-B lymphocyte 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000447$disulfide bond, 790000768$Immunoglobulin domain, 790001212$polymorphism, 790001405$signal]
pre-B lymphocyte 1,UP_SEQ_FEATURE[850025607$chain:Immunoglobulin iota chain, 850102883$disulfide bond, 850104407$domain:Ig-like V-type, 850105852$helix, 850111287$region of interest:Complementarity-determining-1, 850111288$region of interest:Complementarity-determining-2, 850111703$region of interest:Framework-1, 850111704$region of interest:Framework-2, 850111705$region of interest:Framework-3, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
protein inhibitor of activated STAT, 4,INTERPRO[450002665$IPR003034:DNA-binding SAP, 450003691$IPR004181:Zinc finger, MIZ-type]
protein inhibitor of activated STAT, 4,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis, 470038866$hsa04630:Jak-STAT signaling pathway, 470038899$hsa05200:Pathways in cancer, 470038912$hsa05222:Small cell lung cancer]
protein inhibitor of activated STAT, 4,SMART[760000456$SM00513:SAP]
protein inhibitor of activated STAT, 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000466$dna-binding, 790000811$isopeptide bond, 790000937$metal-binding, 790001065$nucleus, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation, 790001593$ubl conjugation pathway, 790001642$wnt signaling pathway, 790001648$zinc, 790001651$zinc-finger]
protein inhibitor of activated STAT, 4,UP_SEQ_FEATURE[850016599$chain:E3 SUMO-protein ligase PIAS4, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850104998$domain:PINIT, 850105257$domain:SAP, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117558$short sequence motif:LXXLL motif, 850118927$zinc finger region:SP-RING-type]
ras homolog gene family, member G (rho G),INTERPRO[450001599$IPR001806:Ras GTPase, 450003145$IPR003578:Ras small GTPase, Rho type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras]
ras homolog gene family, member G (rho G),PIR_SUPERFAMILY[630028684$PIRSF037169:small GTPase, Rho type]
ras homolog gene family, member G (rho G),SMART[760000148$SM00174:RHO]
ras homolog gene family, member G (rho G),SP_PIR_KEYWORDS[790000028$ADP-ribosylation, 790000264$cell membrane, 790000356$complete proteome, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790000953$methylation, 790001063$nucleotide-binding, 790001236$prenylation]
ras homolog gene family, member G (rho G),UP_SEQ_FEATURE[850057602$chain:Rho-related GTP-binding protein RhoG, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850109701$propeptide:Removed in mature form, 850117294$sequence conflict, 850117441$short sequence motif:Effector region]
ribosomal protein S11 pseudogene 5; ribosomal protein S11,INTERPRO[450000231$IPR000266:Ribosomal protein S17, 450011038$IPR012340:Nucleic acid-binding, OB-fold, 450018208$IPR019979:Ribosomal protein S17, conserved site]
ribosomal protein S11 pseudogene 5; ribosomal protein S11,KEGG_PATHWAY[470038813$hsa03010:Ribosome]
ribosomal protein S11 pseudogene 5; ribosomal protein S11,PIR_SUPERFAMILY[630002268$PIRSF002141:Escherichia coli ribosomal protein S17]
ribosomal protein S11 pseudogene 5; ribosomal protein S11,SP_PIR_KEYWORDS[790000012$acetylation, 790000189$blocked amino end, 790000356$complete proteome, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001255$protein biosynthesis, 790001325$ribonucleoprotein, 790001329$ribosomal protein, 790001330$ribosome, 790001339$rna-binding, 790001346$rrna-binding]
ribosomal protein S11 pseudogene 5; ribosomal protein S11,UP_SEQ_FEATURE[850001927$chain:40S ribosomal protein S11, 850106258$modified residue]
serine peptidase inhibitor, Kunitz type 1,INTERPRO[450001927$IPR002172:Low density lipoprotein-receptor, class A, cysteine-rich, 450001971$IPR002223:Proteinase inhibitor I2, Kunitz metazoa, 450010047$IPR011106:Seven cysteines, N-terminal, 450012574$IPR013980:Seven cysteines]
serine peptidase inhibitor, Kunitz type 1,SMART[760000113$SM00131:KU, 760000166$SM00192:LDLa, 760000671$SM00765:MANEC]
serine peptidase inhibitor, Kunitz type 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790001212$polymorphism, 790001253$protease inhibitor, 790001304$repeat, 790001363$Secreted, 790001385$Serine protease inhibitor, 790001405$signal]
serine peptidase inhibitor, Kunitz type 1,UP_SEQ_FEATURE[850027626$chain:Kunitz-type protease inhibitor 1, 850102883$disulfide bond, 850103141$domain:BPTI/Kunitz inhibitor 1, 850103145$domain:BPTI/Kunitz inhibitor 2, 850104664$domain:LDL-receptor class A, 850104754$domain:MANSC, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118488$site:Reactive bond, 850118574$splice variant, 850118575$strand, 850118624$turn]
ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase),INTERPRO[450000534$IPR000626:Ubiquitin, 450001239$IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, 450016487$IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site, 450018184$IPR019954:Ubiquitin conserved site, 450018185$IPR019955:Ubiquitin supergroup]
ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase),PIR_SUPERFAMILY[630013098$PIRSF016322:ubiquitin carboxyl-terminal hydrolase]
ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase),SMART[760000186$SM00213:UBQ]
ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000619$glycosyltransferase, 790000743$hydrolase, 790001116$pentosyltransferase, 790001162$phosphoprotein, 790001252$Protease, 790001509$thiol protease, 790001571$tRNA modification, 790001593$ubl conjugation pathway]
ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase),UP_SEQ_FEATURE[850067954$chain:Ubiquitin carboxyl-terminal hydrolase 14, 850105602$domain:Ubiquitin-like, 850105852$helix, 850106258$modified residue, 850118575$strand, 850118624$turn]
zinc finger protein 573,COG_ONTOLOGY[90000073$General function prediction only, 90000118$Transcription / Cell division and chromosome partitioning]
zinc finger protein 573,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 573,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 573,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 573,UP_SEQ_FEATURE[850101755$chain:Zinc finger protein 573, 850104552$domain:KRAB, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118657$zinc finger region:C2H2-type 10, 850118660$zinc finger region:C2H2-type 11, 850118663$zinc finger region:C2H2-type 12, 850118666$zinc finger region:C2H2-type 13, 850118669$zinc finger region:C2H2-type 14, 850118671$zinc finger region:C2H2-type 15, 850118674$zinc finger region:C2H2-type 16, 850118676$zinc finger region:C2H2-type 17, 850118679$zinc finger region:C2H2-type 18, 850118682$zinc finger region:C2H2-type 19, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
